Aneta Stachowicz
Overview
Explore the profile of Aneta Stachowicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Stachowicz A, Wisniewska A, Kus K, Bialas M, Lomnicka M, Toton-Zuranska J, et al.
Int J Mol Sci
. 2021 Jun;
22(11).
PMID: 34070749
Atherosclerosis and nonalcoholic fatty liver disease are leading causes of morbidity and mortality in the Western countries. The renin-angiotensin system (RAS) with its two main opposing effectors, i.e., angiotensin II...
12.
Suski M, Wisniewska A, Kus K, Kiepura A, Stachowicz A, Stachyra K, et al.
Mol Immunol
. 2020 Sep;
127:193-202.
PMID: 32998073
Background: Cellular peptidases are an emerging target of novel pharmacological strategies in inflammatory diseases and cancer. In this context, the dipeptidyl peptidases 8 and 9 (DPP8/9) have gained special attention...
13.
Holda M, Stachowicz A, Suski M, Wojtysiak D, Sowinska N, Arent Z, et al.
Sci Rep
. 2020 Sep;
10(1):14351.
PMID: 32873862
Pulmonary arterial hypertension (PAH) is a rare, fatal, and incurable disorder. Although advances in the understanding of the PAH pathobiology have been seen in recent years, molecular processes underlying heart...
14.
Zabczyk M, Stachowicz A, Natorska J, Olszanecki R, Wisniewski J, Undas A
J Proteomics
. 2019 Aug;
208:103487.
PMID: 31425886
Background: Little is known about fibrin clot composition in relation to its structure and lysability. We investigated plasma clots protein composition and its associations with clot properties. Methods: We studied...
15.
Suski M, Kiepura A, Wisniewska A, Kus K, Skalkowska A, Stachyra K, et al.
Pharmacol Rep
. 2019 May;
71(4):551-555.
PMID: 31129318
Background: In the past two decades, enhanced understanding of the biology of G-protein-coupled receptors (GPRs) has led to the identification of several such receptors as novel targets for free fatty...
16.
Stachowicz A, Wisniewska A, Kus K, Kiepura A, Gebska A, Gajda M, et al.
Int J Mol Sci
. 2019 Mar;
20(7).
PMID: 30925684
Atherosclerosis and nonalcoholic fatty liver disease (NAFLD) are frequent causes of death in the Western countries. Recently, it has been shown that autophagy dysfunction plays an important role in the...
17.
Stachowicz A, Zabczyk M, Natorska J, Suski M, Olszanecki R, Korbut R, et al.
Sci Rep
. 2018 Nov;
8(1):17301.
PMID: 30470809
The prothrombotic fibrin clot phenotype has been reported in patients with thrombotic antiphospholipid syndrome (APS) and venous thromboembolism (VTE). Protein composition of plasma fibrin clots in APS has not been...
18.
Stachowicz A, Olszanecki R, Suski M, Wisniewska A, Kus K, Bialas M, et al.
Clin Exp Pharmacol Physiol
. 2018 Feb;
45(7):711-719.
PMID: 29485188
Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) plays an important role, not only in endothelium-dependent vasodilation but also in lipid and glucose homeostasis in the liver and exerts beneficial...
19.
Glombik K, Stachowicz A, Trojan E, Slusarczyk J, Suski M, Chamera K, et al.
Pharmacol Rep
. 2018 Feb;
70(2):322-330.
PMID: 29477041
Background: Alteration in the brain mitochondrial functions have been suggested to participate, as a relevant factor, in the development of mental disorders. Therefore, the brain mitochondria may be a crucial...
20.
Stachowicz A, Siudut J, Suski M, Olszanecki R, Korbut R, Undas A, et al.
Clin Proteomics
. 2017 Dec;
14:38.
PMID: 29209155
Background: It is well known that fibrin network binds a large variety of proteins, including inhibitors and activators of fibrinolysis, which may affect clot properties, such as stability and susceptibility...